Literature DB >> 10692618

The impact of HIV infection on primary headache. Unexpected findings from retrospective, cross-sectional, and prospective analyses.

S Evers1, B Wibbeke, D Reichelt, B Suhr, R Brilla, I Husstedt.   

Abstract

Headache is one of the most important factors influencing the quality of life in patients infected with the human immunodeficiency virus type 1 (HIV). However, only symptomatic headache but not changes or primary headache types during HIV infection have been studied to date. Therefore, we aimed to determine the impact of an HIV infection on frequency and semiology of different primary headache types. Patients with confirmed HIV type 1 infection underwent a neurological examination, neuroimaging or EEG, and a standardized interview. Time pattern and symptoms of headaches (cross-sectional analysis), changes of headaches preexisting to their infection (longitudinal retrospective analysis), and changes of primary headaches during a 2-year follow-up (longitudinal prospective analysis) were evaluated as were the correlations between these headache patterns and different markers of HIV infection. One hundred thirty-one consecutive HIV-infected patients without evidence of a cerebral manifestation except mild encephalopathy were enrolled. The point prevalence of migraine was 16.0% (confidence interval (CI) 10.1-25.4%), of headache with a semiology of tension-type headache 45.8% (CI 33.7-62.2%), and of other headache types 6.1% (CI 3.0-12.5%). During the natural course of infection, the migraine frequency significantly decreased in the retrospective and in the prospective analyses, whereas the frequency of the headache with a semiology of tension-type headache significantly increased in all three analyses. In 20% of all patients, the tension-type headache could be considered as symptomatic due to the infection but not due to focal or general cerebral lesions. Changes of primary headache were significantly associated with different stages of the infection and with the presence of mild encephalopathy but not with antiretroviral treatment or CD4 cell count. HIV infection seems to be associated with a progressive decrease in migraine frequency and intensity which probably is related to the immunological state of the patients. Tension-type headache becomes more frequent during HIV infection. However, this can in part be related to secondary headache caused by the HIV in less than 50% of patients with tension-type headache. The progressing immunological deficiency of HIV-infected patients seems to influence pain processing of primary headache types in different ways.

Entities:  

Mesh:

Year:  2000        PMID: 10692618     DOI: 10.1016/s0304-3959(99)00266-3

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  13 in total

1.  Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients.

Authors:  Yuqiang Shi; Benjamin B Gelman; Joshua G Lisinicchia; Shao-Jun Tang
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

2.  Gp120 in the pathogenesis of human immunodeficiency virus-associated pain.

Authors:  Su-Bo Yuan; Yuqiang Shi; Jinghong Chen; Xiangfu Zhou; Guangyu Li; Benjamin B Gelman; Joshua G Lisinicchia; Susan M Carlton; Monique R Ferguson; Alai Tan; Sushil K Sarna; Shao-Jun Tang
Journal:  Ann Neurol       Date:  2014-05-28       Impact factor: 10.422

Review 3.  Tension-type headache and systemic medical disorders.

Authors:  Simona Sacco; Silvia Ricci; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2011-12

4.  Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study.

Authors:  P Vivithanaporn; G Heo; J Gamble; H B Krentz; A Hoke; M J Gill; C Power
Journal:  Neurology       Date:  2010-08-25       Impact factor: 9.910

Review 5.  [Epidemiology and therapy of pain and depression during HIV and AIDS].

Authors:  I W Husstedt; D Reichelt; F Kästner; S Evers; K Hahn
Journal:  Schmerz       Date:  2009-12       Impact factor: 1.107

6.  Headache prevalence and its functional impact among HIV-infected adults in rural Rakai District, Uganda.

Authors:  Sachal Sohail; Gertrude Nakigozi; Aggrey Anok; James Batte; Alice Kisakye; Richard Mayanja; Noeline Nakasujja; Kevin R Robertson; Ronald H Gray; Maria J Wawer; Ned Sacktor; Deanna Saylor
Journal:  J Neurovirol       Date:  2019-01-03       Impact factor: 2.643

Review 7.  [Highly active antiretroviral therapy of neuro-AIDS. Side effects on the nervous system and interactions].

Authors:  I W Husstedt; D Reichelt; E Neuen-Jakob; K Hahn; F Kästner; R von Einsiedel; B Vielhaber; G Arendt; S Evers
Journal:  Nervenarzt       Date:  2009-10       Impact factor: 1.214

8.  Wnt signaling in the pathogenesis of human HIV-associated pain syndromes.

Authors:  Yuqiang Shi; Jianhong Shu; Benjamin B Gelman; Joshua G Lisinicchia; Shao-Jun Tang
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-05       Impact factor: 4.147

9.  Reactive Oxygen Species (ROS) are Critical for Morphine Exacerbation of HIV-1 gp120-Induced Pain.

Authors:  Yuqiang Shi; Subo Yuan; Shao-Jun Tang
Journal:  J Neuroimmune Pharmacol       Date:  2020-08-22       Impact factor: 7.285

Review 10.  The differential diagnosis of chronic daily headaches: an algorithm-based approach.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  J Headache Pain       Date:  2007-10-23       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.